1. Sun, Yuankai, Lin, Shiyu, Wang, Hui, Wang, Fang, Tan, Wenfeng. 2024. Regulatory role of PI16 in autoimmune arthritis and intestinal inflammation: implications for Treg cell differentiation and function. In Journal of translational medicine, 22, 327. doi:10.1186/s12967-024-05082-1. https://pubmed.ncbi.nlm.nih.gov/38566233/
2. Kuang, Xiangqin, Zhang, Zhuojun, Li, Difeng, Yang, Jianan, Jiang, Lili. 2023. Peptidase inhibitor (PI16) impairs bladder cancer metastasis by inhibiting NF-κB activation via disrupting multiple-site ubiquitination of NEMO. In Cellular & molecular biology letters, 28, 62. doi:10.1186/s11658-023-00465-6. https://pubmed.ncbi.nlm.nih.gov/37525118/
3. Wang, Pusen, Jiang, Zhongyi, Liu, Xueni, Li, Hao, Zhong, Lin. 2020. PI16 attenuates response to sorafenib and represents a predictive biomarker in hepatocellular carcinoma. In Cancer medicine, 9, 6972-6983. doi:10.1002/cam4.3331. https://pubmed.ncbi.nlm.nih.gov/32779397/
4. Hazell, Georgina G J, Peachey, Alasdair M G, Teasdale, Jack E, Newby, Andrew C, White, Stephen J. 2016. PI16 is a shear stress and inflammation-regulated inhibitor of MMP2. In Scientific reports, 6, 39553. doi:10.1038/srep39553. https://pubmed.ncbi.nlm.nih.gov/27996045/
5. Chen, Qun, Jiang, Lu-Yang, Cao, Cheng, Wu, Peng-Fei, Jiang, Kui-Rong. 2024. Peptidase inhibitor 16 promotes proliferation of pancreatic ductal adenocarcinoma cells through OASL signaling. In Molecular carcinogenesis, 63, 938-950. doi:10.1002/mc.23699. https://pubmed.ncbi.nlm.nih.gov/38353288/